<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03860129</url>
  </required_header>
  <id_info>
    <org_study_id>RUB 4780-13-B</org_study_id>
    <nct_id>NCT03860129</nct_id>
  </id_info>
  <brief_title>Different Volatile Anaesthetics and the Depth of Long Term ICU Sedation</brief_title>
  <official_title>Depth of Long Term ICU Sedation Under 0,5 MAC Isoflurane, Sevoflurane or Desflurane Using MIRUS, an Automated Delivery System for Volatile Anaesthetics</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ruhr University of Bochum</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ruhr University of Bochum</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The MIRUS system (TIM, Andernach, Germany) as well as the AnaConDa uses a reflector to
      conserve volatile anaesthetics (VA). Both systems can be paired with ICU ventilators, but
      MIRUS features an automated control of end-tidal VA concentrations (etVA). We compare depth
      of 0.5 MAC inhalational long-term sedation with Isoflurane (ISO), Sevoflurane (SEVO) or
      Desflurane (DES).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study was approved by the appropriate Institutional Review Board. Thirty ASA II-IV
      patients, undergoing elective or emergency surgery under general anaesthesia were included
      and randomized into three equal groups: ISO, SEVO or DES. We used MIRUS, a gas delivery
      system with a VA reflector, just like AnaConDa, that can be paired with common ICU
      ventilators. Additionally, MIRUS features the unique ability to maintain the end-tidal
      concentration (etVA) in target by automatically adjusting the delivery rate. Every 8 hours,
      the RASS was assessed by the nurse. The log of the EEG-Narcotrend Index (NI) was also
      included in the study.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 10, 2014</start_date>
  <completion_date type="Actual">May 31, 2017</completion_date>
  <primary_completion_date type="Actual">May 5, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>usage of volatile anesthetics at 0.5 MAC during ICU Sedation</measure>
    <time_frame>up to one week</time_frame>
    <description>Comparison between Isofluarne, Sevoflurane and Desflurane</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Intensive Care Unit Syndrome</condition>
  <arm_group>
    <arm_group_label>ISO</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Drug name: Isoflurane Dosage form: inhalational Dosage: ml/h Concentration: 0.5 MAC (0.5 Vol%)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SEVO</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Drug name: Sevoflurane Dosage form: inhalational Dosage: ml/h Concentration: 0.5 MAC (1.0 Vol%)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>DES</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Drug name: Desflurane Dosage form: inhalational Dosage: ml/h Concentration: 0.5 MAC (3.0 Vol%)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Isoflurane</intervention_name>
    <description>Group A: Isoflurane (0.5 MAC)</description>
    <arm_group_label>ISO</arm_group_label>
    <other_name>Forene</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sevoflurane</intervention_name>
    <description>Group B: Sevoflurane (0.5 MAC)</description>
    <arm_group_label>SEVO</arm_group_label>
    <other_name>Sevorane</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Desflurane</intervention_name>
    <description>Group C: Desflurane (0.5 MAC)</description>
    <arm_group_label>DES</arm_group_label>
    <other_name>Suprane</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Signing of the informed consent document (patient or relatives).

          -  Patient age 18 years or older.

          -  ASA I-III

        Exclusion Criteria:

          -  ASA IV patients

          -  Epidural or spinal analgesia

          -  Allergy or known hypersensitivity to any of the study drugs

          -  Patients with known or suspected genetic susceptibility to malignant hyperthermia

          -  Previous participation in this trial

          -  Participation in another clinical trial within 4 weeks prior to selection.

          -  Pregnant women
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas Weber, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ruhr-University of Bochum, Germany</affiliation>
  </overall_official>
  <reference>
    <citation>Bomberg H, Glas M, Groesdonk VH, Bellgardt M, Schwarz J, Volk T, Meiser A. A novel device for target controlled administration and reflection of desflurane--the Mirus™. Anaesthesia. 2014 Nov;69(11):1241-50. doi: 10.1111/anae.12798. Epub 2014 Jul 9.</citation>
    <PMID>25040673</PMID>
  </reference>
  <reference>
    <citation>Romagnoli S, Chelazzi C, Villa G, Zagli G, Benvenuti F, Mancinelli P, Arcangeli G, Dugheri S, Bonari A, Tofani L, Belardinelli A, De Gaudio AR. The New MIRUS System for Short-Term Sedation in Postsurgical ICU Patients. Crit Care Med. 2017 Sep;45(9):e925-e931. doi: 10.1097/CCM.0000000000002465.</citation>
    <PMID>28441236</PMID>
  </reference>
  <reference>
    <citation>Bellgardt M, Drees D, Vinnikov V, Procopiuc L, Meiser A, Bomberg H, Gude P, Vogelsang H, Weber TP, Herzog-Niescery J. Use of the MIRUS™ system for general anaesthesia during surgery: a comparison of isoflurane, sevoflurane and desflurane. J Clin Monit Comput. 2018 Aug;32(4):623-627. doi: 10.1007/s10877-018-0138-z. Epub 2018 Apr 9.</citation>
    <PMID>29633099</PMID>
  </reference>
  <verification_date>February 2019</verification_date>
  <study_first_submitted>September 24, 2018</study_first_submitted>
  <study_first_submitted_qc>February 28, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 1, 2019</study_first_posted>
  <last_update_submitted>February 28, 2019</last_update_submitted>
  <last_update_submitted_qc>February 28, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 1, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ruhr University of Bochum</investigator_affiliation>
    <investigator_full_name>Martin Bellgardt</investigator_full_name>
    <investigator_title>Prof. Dr. med. Thomas Weber, Director Anesthesiology department St. Josef-Hospitital</investigator_title>
  </responsible_party>
  <keyword>inhalational Sedation</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sevoflurane</mesh_term>
    <mesh_term>Desflurane</mesh_term>
    <mesh_term>Isoflurane</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

